WHO Launches COVID-19 Technology Access Pool
IGBA Supports C-TAP, Which Encourages Sharing IP And Data
Executive Summary
C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica.
You may also be interested in...
MPP And WHO Announce COVID Technology License Via C-TAP
The WHO and Medicines Patent Pool have announced “the first transparent, global, non-exclusive license for a COVID-19 technology” after striking a deal for a COVID-19 serological antibody technology with the Spanish National Research Council through the WHO’s COVID-19 Technology Access Pool.
MPP And IGBA Initiatives Bolster COVID-19 Access
The Medicines Patent Pool and the International Generic and Biosimilar medicines Association have announced separate initiatives with the continued intention to facilitate access to COVID-19 treatments and vaccines, as the global threat from the novel coronavirus pandemic continues.
Coronavirus Update: GSK Stresses Need For Broad Vaccines Amid Future Pandemic Risk
Also, Neoimmune looks to interleukin therapy for mild therapy while Daiichi Sankyo bets on a mRNA vaccine.